a best-in-class suite of transgenic mouse strains designed to address the many challenges across antibody drug discovery and development. AlivaMab Discovery Services (ADS) offers innovative ...

The human anti-mouse antibody (HAMA) reaction limits the therapeutic utility of mouse monoclonal antibodies. Humanization of mouse monoclonal antibodies by genetic engineering can improve the in ...

The impacts of next-generation sequencing (NGS) can be seen throughout multiple phases of therapeutic antibody development, from discovery and engineering to manufacturing. Sequencing is a ...